Imac Holdings, INC 8-K filings

IMAC Holdings has amended its previous 8-K filing to clarify that the appointment of Marcum LLP as its new independent auditor is subject to the firm's client acceptance procedures.

IMAC Holdings has been notified by Nasdaq that it has regained compliance with the minimum stockholders' equity requirement for continued listing.

IMAC Holdings has regained compliance with Nasdaq's minimum stockholders' equity requirement after abandoning a merger with Theralink Technologies and acquiring certain of its assets.

IMAC Holdings has changed its independent auditor to Marcum, LLP and added two new members to its Board of Directors, effective June 26, 2024.

IMAC Holdings has issued senior promissory notes totaling $1.4 million, with a purchase price of $1 million, maturing no later than June 18, 2025.

IMAC Holdings has announced the resignation of its CEO and a director, along with the appointment of a new CEO, effective immediately.

IMAC Holdings, Inc. has issued warrants to purchase common stock as part of a securities purchase agreement.

IMAC Holdings terminated its merger agreement with Theralink Technologies after acquiring Theralink's assets through a settlement agreement.

IMAC Holdings has entered into agreements to acquire Theralink Technologies' debt, settle a credit agreement, and terminate a previously planned merger, issuing new preferred stock in the process.

IMAC Holdings, Inc. has entered into agreements to exchange existing preferred stock and warrants for new securities and to sell additional preferred stock and warrants in a private placement.

IMAC Holdings has appointed Salberg & Company as its new independent registered public accounting firm, following the resignation of its previous auditor.